These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

908 related items for PubMed ID: 19232840

  • 1. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG, Uner A, Yildiz I, Guler G, Takahashi M.
    Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
    [Abstract] [Full Text] [Related]

  • 2. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 3. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E.
    Cancer; 2003 Mar 15; 97(6):1573-81. PubMed ID: 12627523
    [Abstract] [Full Text] [Related]

  • 4. [Relationship of oncogene C-erbB2 expression to ER, PR and PS2 in breast cancer and its prognostic significance].
    Yang JQ, Chen L, Xing TY.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May 15; 35(3):334-6, 357. PubMed ID: 15181828
    [Abstract] [Full Text] [Related]

  • 5. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Bircan S, Kapucuoglu N, Baspinar S, Inan G, Candir O.
    Pathol Res Pract; 2006 May 15; 202(8):569-76. PubMed ID: 16828238
    [Abstract] [Full Text] [Related]

  • 6. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast.
    Lee A, Park WC, Yim HW, Lee MA, Park G, Lee KY.
    Jpn J Clin Oncol; 2007 Sep 15; 37(9):708-14. PubMed ID: 17940078
    [Abstract] [Full Text] [Related]

  • 7. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.
    Hanley K, Wang J, Bourne P, Yang Q, Gao AC, Lyman G, Tang P.
    Hum Pathol; 2008 Mar 15; 39(3):386-92. PubMed ID: 18187183
    [Abstract] [Full Text] [Related]

  • 8. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 Mar 15; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

  • 9. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I, Makovitzky J, Jeschke U, Briese V, Friese K, Gerber B.
    Anticancer Res; 2005 Mar 15; 25(3A):1719-23. PubMed ID: 16033090
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
    Kusińska R, Potemski P, Jesionek-Kupnicka D, Kordek R.
    Pol J Pathol; 2005 Mar 15; 56(3):107-10. PubMed ID: 16334976
    [Abstract] [Full Text] [Related]

  • 11. Histological category and expression of hormone receptors in ductal carcinoma in situ of the breast.
    Lebrecht A, Buchmann J, Hefler L, Lampe D, Koelbl H.
    Anticancer Res; 2002 Mar 15; 22(3):1909-11. PubMed ID: 12168892
    [Abstract] [Full Text] [Related]

  • 12. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA.
    Cancer Res; 2002 Mar 15; 62(6):1676-81. PubMed ID: 11912139
    [Abstract] [Full Text] [Related]

  • 13. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia.
    Arafah M.
    Turk Patoloji Derg; 2012 Mar 15; 28(1):38-43. PubMed ID: 22207430
    [Abstract] [Full Text] [Related]

  • 14. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S, Wang J, Bourne P, Yang Q, Tang P.
    Ann Clin Lab Sci; 2007 Mar 15; 37(2):127-34. PubMed ID: 17522367
    [Abstract] [Full Text] [Related]

  • 15. [Immunohistochemical study on the expression of c-erbB2 oncoprotein in breast tumors].
    Zhang Z, Xu G, Liu S.
    Zhonghua Zhong Liu Za Zhi; 1997 Jul 15; 19(4):287-9. PubMed ID: 11038761
    [Abstract] [Full Text] [Related]

  • 16. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P.
    Breast J; 2005 Jul 15; 11(4):278-80. PubMed ID: 15982396
    [Abstract] [Full Text] [Related]

  • 17. Expression and mutational analysis of GATA3 in Malaysian breast carcinomas.
    Bong PN, Zakaria Z, Muhammad R, Abdullah N, Ibrahim N, Emran NA, Syed Hussain SN.
    Malays J Pathol; 2010 Dec 15; 32(2):117-22. PubMed ID: 21329183
    [Abstract] [Full Text] [Related]

  • 18. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL.
    Breast Cancer Res Treat; 2007 Mar 15; 101(3):279-84. PubMed ID: 16835704
    [Abstract] [Full Text] [Related]

  • 19. C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu.
    Diallo R, Rody A, Jackisch C, Ting E, Schaefer KL, Kissler S, Karn T, Geddert H, Engels K, Kaufmann M, Gabbert HE, Shroyer KR, Poremba C.
    Hum Pathol; 2006 Feb 15; 37(2):205-11. PubMed ID: 16426921
    [Abstract] [Full Text] [Related]

  • 20. Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.
    Joensuu H, Isola J, Lundin M, Salminen T, Holli K, Kataja V, Pylkkänen L, Turpeenniemi-Hujanen T, von Smitten K, Lundin J.
    Clin Cancer Res; 2003 Mar 15; 9(3):923-30. PubMed ID: 12631589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.